Steven Moylan

Summary

Affiliation: Deakin University
Country: Australia

Publications

  1. pmc The impact of smoking in adolescence on early adult anxiety symptoms and the relationship between infant vulnerability factors for anxiety and early adult anxiety symptoms: the TOPP Study
    Steven Moylan
    School of Medicine, Deakin University, Geelong, Victoria, Australia
    PLoS ONE 8:e63252. 2013
  2. doi request reprint The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications
    S Moylan
    School of Medicine, Deakin University, Geelong, Vic, Australia
    Mol Psychiatry 18:595-606. 2013
  3. doi request reprint Exercising the worry away: how inflammation, oxidative and nitrogen stress mediates the beneficial effect of physical activity on anxiety disorder symptoms and behaviours
    S Moylan
    School of Medicine, Deakin University, Melbourne, Australia
    Neurosci Biobehav Rev 37:573-84. 2013
  4. pmc Cigarette smoking, nicotine dependence and anxiety disorders: a systematic review of population-based, epidemiological studies
    Steven Moylan
    Deakin University School of Medicine, Barwon Health, Geelong, Victoria, Australia
    BMC Med 10:123. 2012
  5. doi request reprint The role of alprazolam for the treatment of panic disorder in Australia
    Steven Moylan
    School of Medicine, Deakin University, Geelong, Australia
    Aust N Z J Psychiatry 46:212-24. 2012
  6. doi request reprint The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder
    Steven Moylan
    School of Medicine, Deakin University, Geelong, Victoria, Australia
    J Clin Psychopharmacol 31:647-52. 2011
  7. pmc So depression is an inflammatory disease, but where does the inflammation come from?
    Michael Berk
    IMPACT Strategic Research Centre, School of Medicine, Deakin University, Geelong, Vic, Australia
    BMC Med 11:200. 2013
  8. pmc Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness
    Michael Berk
    School of Medicine, Deakin University, 75 Pigdon s Road, Waurn Ponds, Geelong, Victoria 3216, Australia
    BMC Med 11:74. 2013
  9. pmc How cigarette smoking may increase the risk of anxiety symptoms and anxiety disorders: a critical review of biological pathways
    Steven Moylan
    Deakin University School of Medicine Barwon Health, Geelong, Victoria, Australia
    Brain Behav 3:302-26. 2013

Detail Information

Publications9

  1. pmc The impact of smoking in adolescence on early adult anxiety symptoms and the relationship between infant vulnerability factors for anxiety and early adult anxiety symptoms: the TOPP Study
    Steven Moylan
    School of Medicine, Deakin University, Geelong, Victoria, Australia
    PLoS ONE 8:e63252. 2013
    ..Given the known adverse health effects of cigarette smoking and significant health burden imposed by anxiety disorders, this study supports the importance of smoking prevention and cessation programs targeting children and adolescence...
  2. doi request reprint The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications
    S Moylan
    School of Medicine, Deakin University, Geelong, Vic, Australia
    Mol Psychiatry 18:595-606. 2013
    ..Evidence-based novel treatments informed by this knowledge are discussed...
  3. doi request reprint Exercising the worry away: how inflammation, oxidative and nitrogen stress mediates the beneficial effect of physical activity on anxiety disorder symptoms and behaviours
    S Moylan
    School of Medicine, Deakin University, Melbourne, Australia
    Neurosci Biobehav Rev 37:573-84. 2013
    ....
  4. pmc Cigarette smoking, nicotine dependence and anxiety disorders: a systematic review of population-based, epidemiological studies
    Steven Moylan
    Deakin University School of Medicine, Barwon Health, Geelong, Victoria, Australia
    BMC Med 10:123. 2012
    ....
  5. doi request reprint The role of alprazolam for the treatment of panic disorder in Australia
    Steven Moylan
    School of Medicine, Deakin University, Geelong, Australia
    Aust N Z J Psychiatry 46:212-24. 2012
    ..To investigate the potential impact of increasing prescription rates of alprazolam for the treatment of panic disorder (PD) in Australia through a review of efficacy, tolerability and adverse outcome literature...
  6. doi request reprint The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder
    Steven Moylan
    School of Medicine, Deakin University, Geelong, Victoria, Australia
    J Clin Psychopharmacol 31:647-52. 2011
    ..The available evidence fails to demonstrate alprazolam as superior to other benzodiazepines for the treatment of panic disorder...
  7. pmc So depression is an inflammatory disease, but where does the inflammation come from?
    Michael Berk
    IMPACT Strategic Research Centre, School of Medicine, Deakin University, Geelong, Vic, Australia
    BMC Med 11:200. 2013
    ..It is similarly accompanied by increased oxidative and nitrosative stress (O&NS), which contribute to neuroprogression in the disorder. The obvious question this poses is 'what is the source of this chronic low-grade inflammation?'..
  8. pmc Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness
    Michael Berk
    School of Medicine, Deakin University, 75 Pigdon s Road, Waurn Ponds, Geelong, Victoria 3216, Australia
    BMC Med 11:74. 2013
    ....
  9. pmc How cigarette smoking may increase the risk of anxiety symptoms and anxiety disorders: a critical review of biological pathways
    Steven Moylan
    Deakin University School of Medicine Barwon Health, Geelong, Victoria, Australia
    Brain Behav 3:302-26. 2013
    ....